# Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients

> **NCT05029791** · NA · RECRUITING · sponsor: **Hospices Civils de Lyon** · enrollment: 100 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** Tumor biopsy
- **OTHER:** Blood sample

## Key facts

- **NCT ID:** NCT05029791
- **Lead sponsor:** Hospices Civils de Lyon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-18
- **Primary completion:** 2031-11-18
- **Final completion:** 2031-11-18
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-12-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05029791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05029791, "Variations of Immune Infiltrate and Cell Plasticity Markers in Treated Metastatic Melanoma Patients". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05029791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*